A framework for seroepidemiologic investigations in future pandemics: insights from an evaluation of WHO’s Unity Studies initiative

Table 3 PIs’ feedback on Unity Studies evaluation areas

Evaluation area	Topic	On-line survey (n = 69)			Interviews (n = 15)
Evaluation area	Topic	No.^a	Mean score	% Positive feedback	No.^a	% Positive feedback
Usefulness^b	Informing PHSM policies	55	3.8	65	12	69
	Informing vaccination policies	52	3.7	58	6	50
	Knowledge generation and communications	61	4.3	87	12	75
Support areas^c	Technical	43	4.4	95	12	92
	Financial	39	3.9	59	11	55
	Laboratory	43	4.0	56	10	30

^aStudies were excluded if a PI reported that usefulness was not known or not known yet
^bWhen narrowing to only SEROPREV studies (n=36), % positive feedback increases to 64%, mean usefulness 3.9; among PI interviews, all six responses were from SEROPREV studies
^cMean scores average the combination of timeliness and adequacy

ISSN: 1478-4505